Czogalla, M., Stöhr, J., Gleim, N., Papsdorf, K., Klagges, S., Hambsch, P., . . . Seidel, C. Short-term survivors with brain metastases have modest benefits from focal and systemic therapies and remain frequent despite improving treatment landscape. Elsevier.
Chicago Style (17th ed.) CitationCzogalla, M., et al. Short-term Survivors with Brain Metastases Have Modest Benefits from Focal and Systemic Therapies and Remain Frequent Despite Improving Treatment Landscape. Elsevier.
MLA (9th ed.) CitationCzogalla, M., et al. Short-term Survivors with Brain Metastases Have Modest Benefits from Focal and Systemic Therapies and Remain Frequent Despite Improving Treatment Landscape. Elsevier.
Warning: These citations may not always be 100% accurate.